FDA Will Review Application Seeking Approval of Truxima for Same Indications as Rituxan
News
The U.S. Food and Drug Administration has accepted for review the biologics license application (BLA) requesting the approval of Truxima (CT-P10), a biosimilar to Rituxan (rituximab), for the treatment of ... Read more